Enveric Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Enveric Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2014 to Q2 2024.
  • Enveric Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 7.59M shares, a 260% increase year-over-year.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.16M shares, a 49.3% increase from 2022.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.45M shares.
  • Enveric Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 2.13M shares, a 124% increase from 2018.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 7.59M +5.48M +260% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 4M +1.92M +92.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.16M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 2.16M +377K +21.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.11M +1.05M +100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 2.08M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 1.79M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 1.05M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q3 2020 5.29M +3.18M +150% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 3.52M +1.49M +73.6% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 3.18M +1.37M +75.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q4 2019 2.13M +1.18M +124% Oct 1, 2019 Dec 31, 2019 10-K/A 2020-08-12
Q3 2019 2.11M -22.1M -91.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 2.03M -16.8M -89.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 1.81M -16.8M -90.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 952K -14M -93.6% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 24.2M +9.47M +64.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 18.8M +4.18M +28.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 18.7M +4.56M +32.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 15M +1.91M +14.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 14.7M +1.06M +7.78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 14.6M +1.77M +13.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 14.1M +2.22M +18.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 13.1M +1.97M +17.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 13.7M +3.66M +36.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 12.8M -4.45M -25.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 11.9M +1.88M +18.8% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q4 2015 11.1M Oct 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 9.99M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 17.3M +7.3M +73.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 9.99M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q2 2014 9.99M Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.